[PHARMACOGENETIC ASPECTS OF TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE (REVIEW)].

Pavlova, L; Kukes, V; Shikh, E; Badriddinova, L; Tsvetkov, D; Berechikidze, I

Pavlova, L; Kukes, V; Shikh, E; Badriddinova, L; Tsvetkov, D; Berechikidze, I.

Affiliation

Pavlova L; 2Sechenov First Moscow state medical UNIVERSITY of the Ministry of health of Russia.
Kukes V; 1Federal state budgetary institution "Scientific center for examination of medical devices" of the Ministry of health of the Russian Federation; 2Sechenov First Moscow state medical UNIVERSITY of the Ministry of health of Russia.
Shikh E; 2Sechenov First Moscow state medical UNIVERSITY of the Ministry of health of Russia.
Badriddinova L; 2Sechenov First Moscow state medical UNIVERSITY of the Ministry of health of Russia.
Tsvetkov D; 2Sechenov First Moscow state medical UNIVERSITY of the Ministry of health of Russia.
Berechikidze I; 2Sechenov First Moscow state medical UNIVERSITY of the Ministry of health of Russia.

Georgian Med News ; (302): 63-68, 2020 May.

Article in Ru | MEDLINE | ID: mdl-32672692

Subject(s)

Heart Failure; Pharmacogenetics; Adrenergic beta-Antagonists; Diuretics; Humans; Torsemide

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pharmacogenetics / Heart Failure Limits: Humans Language: Ru Journal: Georgian Med News Year: 2020 Document type: Article

Search on Google

XML

PubMed Links